3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients

Area of Science:

• Nephrology
• Cardiology
• Medical Imaging

Background:

• Patients with chronic kidney disease (CKD) face high cardiovascular mortality risk.
• Hemodialysis is linked to accelerated atherosclerosis.
• Echocardiography assesses cardiac structure and function, often abnormal in CKD.

Purpose of the Study:

• To identify subclinical cardiovascular risk markers using ABI and echocardiography in end-stage renal disease (ESRD) patients.
• Compare cardiac structure and function in hemodialysis patients, kidney transplant recipients, and controls.
• Evaluate the utility of ABI and echocardiographic parameters in assessing cardiovascular risk in CKD.

Main Methods:

• Ankle-brachial index (ABI) measurements.
• 2D and 3D echocardiography to assess left ventricular (LV) structure and function.
• Comparison of cardiac parameters across ESRD (dialysis), post-transplant, and control groups.

Main Results:

• Cardiac structural changes are more pronounced than functional changes in hemodialysis patients.
• 3D echocardiography is more sensitive than 2D for assessing myocardial changes in CKD.
• Kidney transplantation showed a trend towards favorable cardiac remodeling, particularly in function, but differences were non-significant.

Conclusions:

• Ankle-brachial index (ABI) is not suitable for screening cardiovascular risk in ESRD patients.
• 3D echocardiography is superior for detecting cardiac abnormalities in CKD.
• Kidney transplantation may offer benefits for cardiac health in ESRD patients.